We limit data available in the Overview Report for users who do not have Powerpack
Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Target Price Range
Recommendation Rating
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 7.24 | 11.26 | 10.12 | 5.99 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 17.59 | 17.75 | 18.45 | 12.84 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 155 | 178 | 380 | 275 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.35 | 0.70 | 0.62 | 0.91 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 53.61 | 124.73 | 235.82 | 251.22 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 78.35% | 62.10% | 59.17% | 74.93% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (35.71) | (24.22) | (59.84) | (101.01) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (66.60%) | (19.42%) | (25.38%) | (40.21%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (35.24) | (23.23) | (58.92) | (95.80) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.95) | 5.23 | 19.95 | 41.95 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 1.17 | 2.73 | 5.02 | 5.32 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.48 | 0.18 | (10.71) | (5.93) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.54 | 0.81 | 0.02 | (1.11) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.54 | 0.81 | 0.02 | (1.11) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.54 | 31.00 | 21.21 | 17.66 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 45.72 | 45.64 | 46.97 | 47.18 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 1.45 | 177.70 | 0.00 | 0.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.29 | 5.89 | 2.52 | 1.46 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.59 | 0.52 | 0.60 | 0.44 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 83.03 | 33.60 | 17.86 | 2.25 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 63.26 | 113.42 | 5,526.10 | (10.83) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 70.37 | 36.95 | 0.76 | (52.28) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| — | — | — | — | — | — | — | — | — | — | — | — | — | Capex |
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 70.37 | 36.95 | 0.76 | (52.28) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (927.00) | (119.37) | (289.43) | (97.90) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,746.00 | 3,475.00 | 150.00 | 117.56 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,685.00 | 3,455.78 | 102.73 | 49.12 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,305.00 | 1,414.61 | 996.12 | 833.19 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.15% | 0.04% | (6.75%) | (5.09%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.23%) | 0.07% | (0.55%) | (3.21%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 43.50% | 0.27% | (46.16%) | (28.61%) | — | — | — |
ROE
|
Octave Specialty Group, Inc. (OSG) Latest News
13 Aug
Octave Specialty Group (OSG) released its Q2 2026 earnings call transcript covering financial results, operational updates, and management outlook. Quarterly earnings updates and guidance influence near-term investor sentiment and valuation without altering long-term company trajectory.
10 Aug
OSG's Q2 earnings call emphasized MGA growth while issuing mixed guidance. Q2 earnings call with mixed guidance on MGA growth can moderately shift OSG market sentiment and near-term performance outlook.
8 Aug
Octave Specialty Group, Inc. (OSG) held its Q2 earnings call, covering financial results, operational updates, and forward guidance for investors and analysts. Q2 earnings call details on results and guidance can materially shift investor views and near-term stock trajectory.
6 Aug
Octave Specialty Group, Inc. reported its second quarter 2026 financial results. Quarterly earnings reports typically deliver moderate influence on near-term market sentiment and valuation without guaranteeing fundamental shifts.
3 Aug
Octave Specialty Group, Inc. (OSG) is scheduled to report Q2 earnings with analyst forecasts and key expectations outlined for the quarter. Q2 earnings release carries potential for moderate short-term effects on stock price and sentiment.
16 Jun
Octave Specialty Group, Inc. (OSG) receives Strong Buy upgrade. Analyst upgrade to Strong Buy can lift near-term investor sentiment and share price.
14 May
Octave Specialty Group, Inc. (OSG) released Q1 earnings call highlights covering financial results, operational updates, and forward-looking guidance. Q1 earnings call highlights provide insights into financial performance and strategic direction with moderately noticeable influence on OSG's trajectory.
6 May
Octave Specialty Group, Inc. (OSG) reported first quarter 2026 results. Quarterly earnings reports signal financial performance and guide future market expectations for OSG.
19 Mar
Octave Specialty Group (OSG) stock plunged 15.5% over four weeks but shows strong turnaround potential due to undervaluation, solid fundamentals, and positive catalysts. Stock's 15.5% drop highlights turnaround opportunities that could moderately boost financial performance and investor sentiment.
25 Feb
Octave Specialty Group, Inc. (OSG) released Q4 earnings call highlights detailing financial performance, strategic updates, and future outlook. Q4 earnings call highlights disclose financial results and guidance that significantly shape investor expectations and stock trajectory.
24 Feb
Octave Specialty Group Inc (OSG) highlighted strong revenue growth in Q4 2025 earnings call amidst challenges. Strong revenue growth in Q4 2025 earnings signals major positive shift in financial trajectory and investor sentiment.
Octave Specialty Group, Inc. (OSG) earnings call transcript details quarterly financial results, management commentary on performance, strategic updates, and analyst Q&A. Earnings call transcripts provide direct insights into financials, guidance, and strategy, significantly impacting investor sentiment and stock trajectory.
23 Feb
Octave Specialty Group, Inc. (OSG) reported fourth quarter 2025 results. Quarterly financial results disclosure significantly impacts stock price, investor sentiment, and future market performance.
Octave Specialty Group, Inc. (OSG) reported a Q4 net loss and missed revenue estimates. Q4 loss and revenue miss will noticeably affect OSG's financial performance and investor sentiment but remain balanced by annual context.
Octave Specialty Group, Inc. (OSG) released Q4 earnings snapshot. Q4 earnings snapshot affects financial performance and investor sentiment without fundamentally altering long-term trajectory.
18 Feb
Hammurabi, a Division of Xchange Benefits, unveils AI platform revolutionizing medical stop loss underwriting. AI platform launch revolutionizes core underwriting process, positioning OSG for significant competitive and performance gains.
10 Feb
Everspan Group has announced strategic leadership changes, including the appointment of a new CEO and other key executives. These changes are aimed at enhancing the company's operational efficiency and market positioning. The leadership transition is expected to drive growth and innovation within the organization, aligning with Everspan's long-term strategic goals. Leadership changes may moderately influence the company's operational effectiveness and market sentiment.
10 Jan
Analysts are increasingly optimistic about Octave Specialty Group, Inc. (OSG) due to recent strategic initiatives and market positioning that suggest potential growth. The company is focusing on enhancing its service offerings and expanding its market reach, which could lead to improved financial performance. Positive sentiment among analysts indicates a shift in perception regarding OSG's future prospects, driven by these developments. Recent strategic initiatives and market positioning are expected to significantly influence OSG's future performance.
12 Dec
Octave Specialty Group, Inc. (OSG) reported a strong performance in Q3, exceeding expectations and highlighting strategic deals that position the company for future growth. The results indicate robust financial health and a commitment to innovation, which could enhance OSG's competitive edge in the market. Analysts are optimistic about the company's trajectory following these developments. Strategic deals and strong Q3 performance are likely to significantly impact OSG's future and market positioning.
28 Nov
Octave Specialty Group, Inc. (OSG) is experiencing a shift in its growth narrative following recent acquisitions and analysts raising their price targets. These strategic moves are expected to enhance OSG's market position and financial performance, indicating a positive outlook for the company's future. Recent acquisitions and raised price targets are likely to significantly impact OSG's future performance and market positioning.
13 Nov
Ambac Financial Group, Inc. (AMBC) has been upgraded to a 'Buy' rating by analysts, reflecting positive sentiment regarding the company's financial health and growth prospects. This upgrade is attributed to improved performance metrics and strategic initiatives that are expected to enhance shareholder value. Investors are encouraged to consider this upgrade as a potential indicator of future stock performance. The upgrade to a 'Buy' rating indicates significant positive sentiment that could influence investor behavior and market performance.
Ambac Financial Group, Inc. is exploring potential catalysts that could positively influence the narrative surrounding Octave Specialty Group. Key factors include strategic partnerships, market expansion opportunities, and regulatory developments that may enhance the company's competitive positioning and financial performance. Stakeholders are closely monitoring these elements as they could significantly impact investor sentiment and the overall trajectory of Ambac's operations. Strategic partnerships and market expansion could significantly alter Ambac's competitive position and investor sentiment.
Wall Street analysts project a 48.03% upside for Ambac Financial Group, Inc. (AMBC), driven by positive market sentiment and potential growth opportunities. The company's financial health and strategic positioning are highlighted as key factors contributing to this optimistic outlook. Investors are encouraged to consider these insights when evaluating AMBC's stock performance. Analysts' predictions indicate significant potential for growth, which could influence investor sentiment and market dynamics.
10 Nov
Ambac Financial Group, Inc. reported a loss for Q3, exceeding revenue estimates. The company's financial performance showed challenges, but revenue figures were better than analysts anticipated, indicating some resilience in its operations despite the loss. The loss in Q3 may affect investor sentiment and financial performance, but the revenue beat suggests some stability.
Ambac Financial Group, Inc. has rebranded itself as Octave Specialty Group, Inc. The rebranding reflects a strategic shift in focus and aims to enhance the company's identity in the specialty insurance market. This change is part of a broader initiative to align the company's operations with its evolving business model and market opportunities. Rebranding may moderately influence market perception and operational focus but is not expected to drastically alter the company's trajectory.
Ambac Financial Group, Inc. reported its Q3 earnings, highlighting key financial metrics and performance indicators. The company showed improvements in certain areas, reflecting its ongoing strategies and market conditions. Investors are closely monitoring these results to gauge future performance and market positioning. The earnings report indicates moderate changes in financial performance that could influence investor sentiment and operational aspects.
Ambac Financial Group, Inc. reported its third quarter 2025 results, highlighting key financial metrics and performance indicators. The company showed improvements in revenue and net income compared to the previous quarter, driven by strategic initiatives and favorable market conditions. Ambac's management provided insights into future growth prospects and ongoing risk management efforts, emphasizing their commitment to enhancing shareholder value. The reported financial improvements and strategic initiatives indicate a moderately noticeable influence on Ambac's future performance.
Ambac Financial Group, Inc. has appointed Karen Beyer as the new Head of Investor Relations. Beyer brings extensive experience in investor relations and corporate communications, having previously held senior roles at various financial institutions. Her appointment is expected to enhance Ambac's engagement with investors and improve communication strategies. The appointment of a new Head of Investor Relations may moderately influence investor sentiment and communication effectiveness.
6 Nov
Third Avenue Small-Cap Value Fund has updated its position on Ambac Financial Group, Inc. (AMBC), indicating a strategic interest in the company's potential for growth. The fund's analysis highlights key financial metrics and market conditions that could influence AMBC's performance moving forward. Investors are encouraged to consider these insights as they evaluate their positions in the stock. The updates from Third Avenue suggest a moderately noticeable influence on Ambac's financial performance and market sentiment.
3 Nov
Ambac Financial Group, Inc. has successfully completed its acquisition of ArmadaCare, a provider of specialty insurance solutions. This strategic move is expected to enhance Ambac's offerings and expand its market presence in the insurance sector. The acquisition aligns with Ambac's growth strategy and aims to leverage ArmadaCare's expertise in providing innovative insurance products. The acquisition is a significant strategic move that could enhance Ambac's market position and product offerings.